KR910700065A - 디모펜틴을 함유한 피부장애 국소 치료용 조성물 - Google Patents
디모펜틴을 함유한 피부장애 국소 치료용 조성물Info
- Publication number
- KR910700065A KR910700065A KR1019900701984A KR900701984A KR910700065A KR 910700065 A KR910700065 A KR 910700065A KR 1019900701984 A KR1019900701984 A KR 1019900701984A KR 900701984 A KR900701984 A KR 900701984A KR 910700065 A KR910700065 A KR 910700065A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- alcohol
- dimopentin
- surfactant
- glycerin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/32—Thymopoietins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (26)
- 유효량의 디모펜틴 또는 그 유사체를 약제학적으로 허용되는 담체에 함유시켜서 되는 피부장애의 국소치료용 조성물.
- 제1항에 있어서, 그 량이 디모펜틴 약 0.1-약 10wt.%인 조성물.
- 제1항에 있어서, 담체를 크림, 겔, 연고 및 로유션 중에서 선택하여서 되는 조성물.
- 제1항에 있어서, 담체가 수중유적형(O/W 형)에멀젼인 조성물.
- 제1항에 있어서, 친유성을 가지며 소수성말단을 가진 탄소원자수 18이하의 긴 사슬의 알킬 또는 알케닐 화합물을 최소한 한가지를 함유하는 조성물.
- 제5항에 있어서, 화합물이 스테아릴 알코올, 세틸 알코올, 올레일 알코올, 말레익 알코올 또는 팔미틸 알코올 중에서 선택되는 지방산 알코올 또는 지방 알코올인 조성물.
- 제1항에 있어서, 보습제를 함유하는 조성물.
- 제7항에 있어서, 보습제가 글리세린인 조성물.
- 제1항에 있어서, 왁스질의 피부 표현을 침투할 수 있는 물질을 함유하는 조성물.
- 제9항에 있어서, 이 물질이 계면활성제인 조성물.
- 제10항에 있어서, 계면활성제를 소디움 라우틸 술페이트 및 폴리옥시 에틸렌 40 스테아레이트 중에서 선택하여서 되는 조성물.
- 제1항에 있어서, 추가로 물을 함유하는 조성물.
- 제1항에 있어서, 추가로 탄소원자수가 16-18 유리지방산을 함유하는 조성물.
- 제13항에 있어서, 지방산을 스테아레이트 및 팔미테이트 중에서 선택하여서 되는 조성물.
- 제1항에 있어서, 조성물을 완충시키고 그 치료 수명을 길게하는 pH 안정제를 추가로 함유하는 조성물.
- 제15항에 있어서, 안정제가 글리신인 조성물.
- 제1항에 있어서, 피부에 대한 디모펜틴의 방출을 촉진하는 임의의 비활성 증강제 성분들을 추가로 함유하는 조성물.
- 제17항에 있어서, 이들 성분을 M피롤, 시트레이트, 말레산, EDTA 및 카르보풀 중에서 선택하여서 되는 조성물.
- 제1항에 있어서, pH가 약 7정도인 조성물.
- 제1항에 있어서, 지방산 알코올 약 30%, 글리세린 약 3-4%, 계면활성제 약 2-5%, 석유 젤리 약 30-35%, 유리지방산 약 0-2% 및 나머지를 물로 함유하는 조성물.
- 제20항에 있어서, pH 안정제, 한가지 이상의 임의의 증강제 및 한가지 이상의 보존제를 추가로 함유하는 조성물.
- 제1항에 있어서, 지방산 알코올 약 2-7%, 글리세린 약 1-3%, 광유 약 5-15%, 계면활성제 약 5-7%, 유리지방산 약 0-3%, 정재수 약 50-70%, pH 안정제 약 0-10% 및 보존제 약 0-0.3%을 함유하는 조성물.
- 제22항에 있어서, 디모펜틴 약 10%, 세틸알코올 및 스테아릴알코올의 혼합물 약 7%, 글리세린 약 1%, 광유 약 15%, 정제수 약 50.7%, 글리신 약 10%, 계면활성제 약 6% 및 보존제 약 0.3%를 함유하는 조성물.
- 치료를 필요로 하는 포유동물의 피부 장애가 있는곳에 유효량의 디모펜틴 또는 그 유사체를 약제학적으로 허용되는 담체중에 함유시킨 국소용 제제를 직접 투여하는 피부장애의 자극을 경감시키는 방법.
- 제24항에 있어서, 피부장애가 습진, 건선, 헤르페스 심플렉스 병변, 옷, 과민선 피부염, 만성 피부염, 접촉 피부염 또는 자극성 피부염을 대상으로 하는 방법.
- 약 2-5마이크론 크기의 초미세분쇄한 디모펜틴 유효량을 에멀젼중에 균일히 분포시키고 조성물의 pH를 약 7이 되게한 디모펜틴 또는 그 유사체로 된 국소용 제제 제조방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29613789A | 1989-01-12 | 1989-01-12 | |
US07/296,137 | 1989-01-12 | ||
US07/452,757 | 1989-12-19 | ||
US07/452,757 US5036050A (en) | 1989-01-12 | 1989-12-19 | Compositions containing thymopentin for topical treatment of skin disorders |
PCT/US1990/000248 WO1990007933A1 (en) | 1989-01-12 | 1990-01-10 | Compositions containing thymopentin for topical treatment of skin disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
KR910700065A true KR910700065A (ko) | 1991-03-13 |
Family
ID=26969508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900701984A KR910700065A (ko) | 1989-01-12 | 1990-01-10 | 디모펜틴을 함유한 피부장애 국소 치료용 조성물 |
Country Status (10)
Country | Link |
---|---|
US (1) | US5036050A (ko) |
EP (1) | EP0378413A3 (ko) |
JP (1) | JPH03503177A (ko) |
KR (1) | KR910700065A (ko) |
AU (1) | AU624222B2 (ko) |
BR (1) | BR9004535A (ko) |
CA (1) | CA2025018A1 (ko) |
FI (1) | FI904475A0 (ko) |
PT (1) | PT92845A (ko) |
WO (1) | WO1990007933A1 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5859066A (en) * | 1996-04-08 | 1999-01-12 | Rutgers, The State University Of New Jersey | Method for the treatment of itching |
DK1324776T4 (en) * | 2000-10-12 | 2018-05-28 | Genentech Inc | CONCENTRATED PROTEIN FORMULATIONS WITH REDUCED VISCOSITY |
EP1503729B1 (de) * | 2002-05-10 | 2010-03-17 | Maria Klewinghaus | Zusammensetzung und deren verwendung als pharmazeutische oder kosmetische formulierung zur äusserlichen anwendung |
US20060177406A1 (en) * | 2005-02-08 | 2006-08-10 | Niazi Sarfaraz K | Formula, a system and a method for treating urushiol induced contact dermatitis |
US20060239943A1 (en) * | 2005-04-21 | 2006-10-26 | Tomasi Nestor S | Formula and method for providing protection from dermatitis, sunlight and/or insects |
US20070218020A1 (en) * | 2006-03-16 | 2007-09-20 | Tomasi Nestor S | Composition and method for providing protection from dermatitis, from urushiol and/or from sunlight |
JP2010539069A (ja) * | 2007-09-11 | 2010-12-16 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | スプレノペンチンおよびチモペンチンの組合せ、ならびに医薬におけるこれらの使用 |
WO2009040067A2 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
AU2008297930A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of octreotide as a therapeutic agent |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1404583A (en) * | 1971-10-08 | 1975-09-03 | Vymatt Sa | Urea compositions and methods of preparation thereof |
US4190646A (en) * | 1975-11-11 | 1980-02-26 | Sloan-Kettering Institute For Cancer Research | Polypeptide compositions and methods |
US4261886A (en) * | 1980-03-13 | 1981-04-14 | Ortho Pharmaceutical Corporation | Peptides having thymopoietin-like activity |
FR2460290A1 (fr) * | 1979-06-29 | 1981-01-23 | Rhone Poulenc Ind | Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent |
DE2938420A1 (de) * | 1979-09-22 | 1981-04-09 | Hoechst Ag, 6000 Frankfurt | Neue peptide und verfahren zu ihrer herstellung |
US4361673A (en) * | 1980-09-19 | 1982-11-30 | American Home Products Corporation | Polypeptide compositions |
HU185263B (en) * | 1981-06-12 | 1984-12-28 | Richter Gedeon Vegyeszet | Process for producing peptides effective on the immuncontroll analogous with the tp5 |
US4614517A (en) * | 1982-08-04 | 1986-09-30 | La Jolla Cancer Research Foundation | Tetrapeptide |
US4505853A (en) * | 1983-11-18 | 1985-03-19 | Ortho Pharmaceutical Corporation | Enzyme-resistant immunomodulatory peptides |
US4547489A (en) * | 1984-06-11 | 1985-10-15 | Ortho Pharmaceutical Corporation | Conformationally restricted thymopentin-like compounds |
US4629723A (en) * | 1984-06-27 | 1986-12-16 | Ortho Pharmaceutical Corporation | Potent thymopentin analogs |
US4753958A (en) * | 1985-02-07 | 1988-06-28 | University Of Cal | Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins |
US4749690A (en) * | 1986-01-27 | 1988-06-07 | Ortho Pharmaceutical Corporation | Treatment of allergy with thymopentin |
DE3633651A1 (de) * | 1986-10-03 | 1988-04-14 | Alfred Dr Dick | Verwendung von fraktionen aus thymus- und milzextrakten zur behandlung der psoriasis |
IT1240314B (it) * | 1989-09-28 | 1993-12-07 | Immunobiology Research Institutes, Inc. | Formulazioni acquose stabilizzate di piccoli peptidi. |
-
1989
- 1989-12-19 US US07/452,757 patent/US5036050A/en not_active Expired - Fee Related
-
1990
- 1990-01-10 CA CA002025018A patent/CA2025018A1/en not_active Abandoned
- 1990-01-10 KR KR1019900701984A patent/KR910700065A/ko not_active Application Discontinuation
- 1990-01-10 JP JP2502852A patent/JPH03503177A/ja active Pending
- 1990-01-10 BR BR909004535A patent/BR9004535A/pt unknown
- 1990-01-10 WO PCT/US1990/000248 patent/WO1990007933A1/en active Application Filing
- 1990-01-10 AU AU50212/90A patent/AU624222B2/en not_active Expired - Fee Related
- 1990-01-11 EP EP19900300324 patent/EP0378413A3/en not_active Ceased
- 1990-01-11 PT PT92845A patent/PT92845A/pt not_active Application Discontinuation
- 1990-09-11 FI FI904475A patent/FI904475A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0378413A3 (en) | 1991-01-23 |
JPH03503177A (ja) | 1991-07-18 |
AU624222B2 (en) | 1992-06-04 |
WO1990007933A1 (en) | 1990-07-26 |
EP0378413A2 (en) | 1990-07-18 |
US5036050A (en) | 1991-07-30 |
FI904475A0 (fi) | 1990-09-11 |
CA2025018A1 (en) | 1990-07-13 |
AU5021290A (en) | 1990-08-13 |
BR9004535A (pt) | 1991-07-30 |
PT92845A (pt) | 1990-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5385943A (en) | Use of topically applicable preparations for treatment of presbyderma | |
US5667789A (en) | Salicylic acid derivative as a stabilizer for an oil-in-water emulsion | |
DE69918775T2 (de) | Ein Bärentraübenextrakt und ein Reduktionsmittel enthaltende Hautdepigmentierungszusammensetzung | |
US4181725A (en) | Method for alleviating psoriasis | |
RU2111745C1 (ru) | Жидкая композиция, предназначенная для местного применения | |
US5079003A (en) | Skin lotions and creams | |
KR920021139A (ko) | 약학 조성물 | |
KR930016085A (ko) | 화장제 조성물 | |
EP0147446A1 (en) | Improved compositions for the treatment of psoriasis | |
KR840006440A (ko) | 국소 외용 약학적 조성물의 제조방법 | |
JP2002527356A (ja) | 異常細胞増殖処置のための組成物および方法 | |
JPS6118718A (ja) | 抗炎症製薬組成物 | |
AU617466B2 (en) | Treatment of skin disorders | |
EP0133437A1 (en) | Vitamin-containing skin care ointment | |
KR910700065A (ko) | 디모펜틴을 함유한 피부장애 국소 치료용 조성물 | |
CA2032733A1 (en) | Topical pharmaceutical compositions | |
JP2915931B2 (ja) | 抗刺激性と除感作の組成物及びその使用方法 | |
US4203969A (en) | Dithranol compositions for topical applications | |
US3867522A (en) | Acne composition | |
US5939084A (en) | Aqueous phase dermatological/cosmetic compositions comprising solubilized melatonin values | |
DE3463728D1 (en) | Sebum secretion accelerator | |
KR910002435A (ko) | 안정한 트레티노인 유화 크림 배합물 | |
EP0103783A2 (de) | Dermatologische Zubereitung | |
CS275816B6 (en) | Cosmetic preparation for use on greasy skin | |
EP0437225B1 (de) | Topische Präparate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |